The Lancet SJR and Scopus Metrics: What the Numbers Actually Tell Authors
The Lancet's Scopus profile is exceptional, but the real submission question is whether the paper has broad enough clinical, policy, or global-health consequence.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: The Lancet remains one of the strongest general-medical journals in the world under Scopus-style metrics. Current Scopus-linked browser data reports a 2024 SJR of 12.113, a CiteScore of 87.6, and near-top placement in medicine. That confirms extraordinary authority, but the submission decision still depends more on whether the manuscript has broad enough consequence than on the metrics alone.
The core metric picture
Metric | 2024 value | What it tells you |
|---|---|---|
SJR | 12.113 | Prestige-weighted influence is exceptionally high |
CiteScore | 87.6 | Four-year citation performance is extraordinary |
SNIP | 22.724 | Field-normalized impact remains huge |
Rank | 3 / 668 in medicine | The journal sits near the very top of medicine |
JCR context | Impact factor 88.5 | Web of Science tells the same flagship story |
The useful reading is that The Lancet remains structurally central to general medicine, not merely famous by reputation.
What the metrics actually help with
They help explain why The Lancet stays so hard to reach:
- it carries enormous cross-field and international visibility
- it has unusual reach in policy, public health, and global-health conversations
- it remains one of the few journals that can shape the medical agenda beyond one specialty
That is useful when authors are choosing between The Lancet, NEJM, JAMA, or a very strong specialty flagship.
What the metrics do not answer
They do not tell you:
- whether the manuscript is broad enough for general medicine
- whether the paper's strongest value is global-health, policy, or direct clinical consequence
- whether another flagship would be a better editorial match
- whether the study is simply too narrow for this audience
Those are still the real editorial questions.
Why the profile matters for authors
At this SJR and CiteScore level, The Lancet is buying authors one of the most powerful readership signals in medicine. But it is buying a particular kind of signal:
- broad international consequence
- strong policy and systems relevance
- papers that matter beyond one specialty room
- unusually high visibility among clinicians, health leaders, and decision-makers
That is why the journal's profile differs from other flagships. The number is huge, but the real issue is the breadth and consequence implied by the editorial room.
What should drive the submission decision instead
The better question is whether the manuscript is truly a Lancet paper.
That is why the better next reads are:
- Is The Lancet a good journal?
- The Lancet submission guide
- The Lancet submission process
- The Lancet acceptance rate
If the paper deserves a broad medical or global-health audience, the metrics support the choice. If it is narrower than that, the same metrics are simply explaining why the bar is severe.
Practical verdict
The Lancet has exceptional Scopus-style metrics and remains a true general-medical flagship. That makes it worth considering for papers with major clinical, international, or policy consequence.
But the useful takeaway is still fit, not prestige intoxication. If the manuscript is not genuinely broad enough, the numbers do not help. A free Manusights scan is the fastest way to pressure-test that before submission.
- The Lancet submission guide, Manusights.
Sources
- 1. The Lancet journal browser entry, Wageningen University & Research.
- 2. The Lancet journal page, Elsevier.
- 3. The Lancet information for authors, Elsevier.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.